The suicide assessment scale: Psychometric properties of a Norwegian language version by Bjørn Koldsland et al.
Koldsland et al. BMC Research Notes 2012, 5:417
http://www.biomedcentral.com/1756-0500/5/417RESEARCH ARTICLE Open AccessThe suicide assessment scale: Psychometric
properties of a Norwegian language version
Bjørn Odd Koldsland1,2†, Lars Mehlum2*†, Liv Solrunn Mellesdal3, Fredrik A Walby2,4 and Lien M Diep2,5Abstract
Background: Rating scales are valuable tools in suicide research and can also be useful supplements to the
clinical interview in suicide risk assessments. This study describes the psychometric properties of a Norwegian
language version of the Suicide Assessment Scale Self-report version (SUAS-S).
Methods: Participants were fifty-two patients (mean age = 39.3 years, SD = 10.7) with major depression (53.8%),
bipolar disorder (25.0%) and/or a personality disorder (63.5%) referred to a psychiatric outpatient clinic. The SUAS-S,
the screening section of the Beck Scale for Suicidal Ideation (BSS-5), the Beck Depression Inventory (BDI), Beck’s
Hopelessness Scale (BHS), the Symptom Check-List-90 R (SCL-90R) and the Clinical Global Impression for Severity of
Suicidality (CGI-SS) were administered. One week later, the patients completed the SUAS-S a second time.
Results: Cronbach’s alpha for SUAS-S was 0.88 and the test–retest reliability was 0.95 (95% CI: 0.93– 0.97). SUAS-S
was positively correlated with the BSS-5 (r = 0.66; 95% CI: 0.47–0.85) for the study sample as a whole and for the
suicidal (r = 0.52) and non-suicidal groups (r = 0.50) respectively. There was no difference between the SUAS-S and
the BSS-5 in the ability to identify suicidality. This ability was more pronounced when the suicide risk was high.
There was a substantial intercorrelation between the score on the SUAS-S and the BDI (0.81) and the BHS (0.76).
The sensitivity and specificity of the SUAS-S was explored and an appropriate clinical cut-off value was assessed.
Conclusions: The study revealed good internal consistency, test–retest reliability and concurrent validity for the Suicide
Assessment Scale Self-report version. The discriminatory ability for suicidality was comparable to that of the BSS-5.Background
Assessment of suicide risk is one of the most challenging
tasks that clinicians working in mental health care face.
The difficulty of the task derives from problems with the
definition of suicidality [1], the fact that suicide risk may
vary considerably with time and across contexts, and,
above all, the low incidence of completed suicide [2]. To
date, the clinical interview has been regarded as the gold
standard for suicide risk assessment [3], but even though
it is very resource demanding it has relatively low sensi-
tivity and specificity. In a clinical context adding a self-
report questionnaire could provide information that would
otherwise remain undetected or undisclosed during the
clinical interview [4]. Furthermore, self-report instruments
could be a useful supplementary low-cost method to* Correspondence: lars.mehlum@medisin.uio.no
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reproduction in any medium, provided the orsecure repeated measurements of suicide risk in contexts
where this is regarded important. Several suicide risk as-
sessment questionnaires have been developed for research
and clinical purposes [5]. These instruments are highly het-
erogeneous. The Suicide Assessment Scale (SUAS) was
developed by Stanley and co-workers [6] as a clinician-
administered rating scale, and was further developed by
Nimeus et al. [7,8] as a self-report instrument (SUAS-S)
[7,9]. The SUAS scale was designed to tap both explicit
suicide risk factors and information on indirect dimensions
relevant to suicidality, such as affective instability and poor
impulse control. The aim of this study was to investigate
the psychometric properties of a Norwegian language
version of the SUAS-S (Additional file 1).Methods
The scale
The SUAS-S is a 20-item self-report rating scale measur-
ing the patient’s attitude towards suicide, suicide-related
behaviour and suicidal ideation on the day of reportingral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Intercorrelations with 95% CIs between scores on
the SUAS-S, BSS-5, BDI and BHS
SUAS-S
Overall (n = 52) Pa
BSS-5 0.66 (0.47–0.85) < 0.001
BDI 0.81 (0.70–0.92) < 0.001
BHS 0.76 (0.61–0.92) < 0.001
aP-values of pairwise correlations in the overall.
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in the range of 0–4 on a Likert-type scale and resulting
in a scale sum score with a range of 0–80. The scale is
designed to measure levels of suicidality and to be sensi-
tive to temporal changes in suicide-related symptoms
[6]. The SUAS-S items cover five thematic areas [6,8]:
“affect” (items 1, 2, 9, 12 and 13), “bodily states” (items
3, 8 and 10), “control and coping” (items 6, 7, 11 and
15), “emotional reactivity” (items 4, 5 and 14) and “sui-
cidal thoughts and behaviour” (items 16–20). The original
SUAS-S scale has been found to possess good concur-
rent validity compared with the interview version [9].
Sample
Fifty-five patients consecutively referred to a psychiatric
outpatient clinic from January 2008 until January 2009,
were asked to participate in the project. Fifty-three
(96%) of the patients provided informed consent and
were included in the study. Of these, one patient dropped
out before all scales were completed and was not in-
cluded in the further analysis. Patients with an on-going
substance abuse and/or psychotic disorder were not eli-
gible to participate in the study. Patients were recruited
from a non-emergency setting.
Ratings
Deliberate self-harm (DSH) was defined as “an act with
non-fatal outcome in which an individual deliberately
initiated behaviour with the intention to cause self-harm,
for example, self-cutting or jumping from a height, by
ingestion of an illicit drug, a non-ingestible substance or
an excess of a prescribed substance”[10,11]. Suicide at-
tempt (SA) was defined as “a potentially self-injurious
behaviour with a nonfatal outcome, for which there is
evidence that the person intended, at some level, to kill
himself/herself”[11]. The Clinical Global Impression of
Severity of Suicidality Scale (CGI-SS) [12] was used in
the baseline assessment to provide an overall clinician
rated measure of the clinical risk of suicidality in each
participant. The CGI-SS has five levels of severity of sui-
cidality; 1 =not at all suicidal, 2 =mildly suicidal, 3 =mod-
erately suicidal, 4 = severely suicidal, and 5 = attempted
suicide. Interviews yielding these scores were made inde-
pendent of and blind to the participants' SUAS-S scores.
Study subjects were categorically classified as “non-
suicidal” if they received scores 1 or “suicidal” if they
were scored 2–5 on the CGI-SS. The baseline assess-
ment also included measuring depressive symptoms with
the Beck Depression Inventory (BDI) [13], feelings of
hopelessness with Beck’s Hopelessness Scale (BHS) [14],
general psychiatric symptoms with the Symptom Check
List-90 R (SCL-90 R) [15], suicidal ideation with the five
items screening section of Beck’s Scale for Suicidal Idea-
tion (BSS-5) [16] and general functioning level with theGlobal Assessment of Functioning (GAF) [17]. The SUAS-S
was administered a second time one week after the first
administration. Psychiatric diagnoses were made at base-
line using the Mini International Neuropsychiatric Inter-
view (M.I.N.I.) [18] for DSM-IV axis I disorders and the
Structured Clinical Interview for DSM-IV Personality
Disorders (SCID-II) [19] for axis II disorders. Interviews
and diagnoses were all made by the first author, an ex-
perienced psychiatrist. In cases where it was unclear
whether criteria for a specific diagnosis were met, the
case was discussed with the second author (a professor
of psychiatry) and settled by consensus. In cases where
the patients had more than one DSM IV axis I or axis II
diagnosis, only the main diagnosis on each axis was con-
sidered in the analyses. Diagnostic data were collected to
provide a good description of this clinical sample. The
study was, however, not designed to study the SUAS-S
properties in diagnostic subgroups.
Statistical analysis
Means and standard deviations, or medians and quar-
tiles, were given for sum scores. The chi-squared test
was used to assess differences in distribution between
the groups for categorical variables. Differences in sum
scores of two independent groups were tested by two-
sample t-test or Mann–Whitney U test. Internal con-
sistency was computed as the Cronbach’s alpha coefficient,
and test–retest reliability was measured with Intra Class
Correlation (ICC) with 95% Confidence Intervals (CIs).
Associations between the sum scores on the SUAS-S and
BSS-5, and their precision, were estimated by Pearson’s
or Spearman’s correlation coefficient and bootstrapped
95% CI with 10,000 replications. Discriminatory ability
of suicidality for the SUAS-S and BSS-5 sum scores was
examined and compared through the use of nonpara-
metric receiver operating characteristic (ROC) curve ana-
lyses. The tests were two-sided, and the significance
level was set at 0.05. The analyses were performed with
STATA 11 [20] and the graphs were made in R 2.11.1 [21].
Ethics
The study was approved by the Regional Committee for
Medical Research Ethics, South-East Norway. All pa-
tients gave written informed consent.
Figure 1 Co-variation between BSS-5 and SUAS-S sum scores shown as a solid line (all patients included).
Table 3 Sensitivity, specificity and predictive probability
of SUAS-S and BSS-5 cut-off points for detecting
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Sample characteristics
The sample consisted of 33 (63.5%) females and 19
males (36.5%) with a mean age of 39.3 years (SD= 10.7,
range = 21–62). Thirty-four patients (65.4%) had been in
psychiatric treatment in total for more than five years,
and 11 (21.2%) for less than a year. The mean GAF score
was 48.6 (SD= 4.6); there were no gender differences.
The mean SCL-90-R score was 1.5 (SD= 0.7), with no
significant gender differences. Twenty-two (42.3%) of the
patients, 16 females and six males, reported a history of
DSH. In 15 (68.2%) of these cases, the criteria for a SA
were met. Five patients reported having had a DSH epi-
sode during the last six months. The median number of
DSH episodes per patient was one, with a range of 0–30.
All but one patient fulfilled the criteria for at least one
axis I disorder. Major Depressive Disorder (MDD) wasTable 2 Test score means with standard deviations and
medians with quartiles and effect size in suicidal and
non-suicidal patients
Suicidal (n = 25) Non-suicidal (n = 27) Effect
size
P
Mean± SD Mean± SD
SUAS-S 33.7 ± 9.7 25.6 ± 9.3 0.85 0.003a
BSS-5* 1.0 (1.0–4.0) 0.0 (0.0–0.3) 1.07** < 0.001b
BDI 23.0 ± 11.0 14.2 ± 8.8 0.89 0.003a
BHS* 11.0 (6.0–16.0) 3.0 (2.8–9.0) 0.92** 0.005b
*Median (Q1-Q3), **Assuming normally distributed data.
aTwo independent samples t-test, bMann–Whitney U test.diagnosed in 28 patients (53.8%), Bipolar Disorder type
II in 13 cases (25.0%) and Dysthymia in 4 cases (7.5%).
These diagnostic groups were merged into one group,
“Affective Disorders” (AD) (n=45). The residual group
(n=7) was labelled “Other Axis I Disorders”. Thirty-three
patients (63.5%) had an axis II diagnosis, of whom five
(9.6%) had a Cluster A disorder, 11 (21.2%) a Cluster B dis-
order, 15 (28.8%) a Cluster C disorder, and two patients had
Personality Disorder Not Otherwise Specified (PF-NOS).
SUAS-S scores
The mean SUAS-S score was 31.0 (SD=9.3) in females and
28.1 (SD=12.7) in males. No significant correlation was found
between age and the SUAS-S score. Patients with AD had asuicidality
Cut-off Sens1(%) Spec2(%) PPV3(%) NPV4(%)
SUAS-S ≥ 28 80 52 61 74
≥ 29 80 56 63 75
≥ 30 68 63 63 68
≥ 31 68 67 65 69
BSS-5 ≥ 0 100 0 77 81
≥ 1 80 78 77 40
≥ 2 36 93 82 61
≥ 3 32 96 78 52
1Sensitivity, 2Specificity, 3Positive predictive probability, 4Negative predictive
probability.
Table 4 Mean scores with standard deviations, medians
with quartiles and effect size for the five SUAS-S
thematic areas
Suicidal (n = 25) Non-suicidal (n = 27) Effect
size
P
Mean± SD Mean± SD
Affect 10.2 ± 2.6 8.7 ± 2.4 0.60 0.030a
Bodily States 5.0 ± 2.0 4.4 ± 2.1 0.29 0.364a
CaC 6.1 ± 2.0 5.2 ± 2.1 0.44 0.106a
ER 5.0 ± 2.3 4.6 ± 2.3 0.17 0.526a
STaB* 8.0 (5.0 - 11.0) 1.0 (0.0 - 4.0) 1.15** < 0.001b
CaC: Control and coping, ER: Emotional reactivity, STaB: suicidal thoughts and
behaviour.
aTwo independent sample t-test, bMann-Whitney U test.
*Median (Q1-Q3), **Assuming normally distributed data.
Koldsland et al. BMC Research Notes 2012, 5:417 Page 4 of 6
http://www.biomedcentral.com/1756-0500/5/417significantly higher median SUAS-S score (median=31.0,
quartiles = 24.5–39.0) than patients with other axis I disor-
ders (median=19, Q1-Q3 quartiles = 15–31), (p =0.018).Psychometric properties of the SUAS-S
Internal consistency, as measured by Cronbach’s alpha coef-
ficient, was found to be 0.88 (95% CI: 0.82–0.92). The test–
retest reliability expressed by the ICC was 0.95 (95% CI:
0.93–0.97). Concurrent validity was examined by pairwise
correlations with 95% CIs between SUAS-S, BSS-5, BDI
and BHS-scores for all patients, as shown in Table 1.
SUAS-S was generally strongly correlated with these
measures, but somewhat weaker with BSS-5. The non-
linear co-variation between the BSS-5 and SUAS-S
scores is more clearly shown in Figure 1. The association
implies a tendency for scores on the BSS-5 to increase
only after the SUAS-S scores have exceeded 30. The
mean and median SUAS-S and BSS-5 scores as well as
the BDI and BHS scores were significantly higher in
patients classified according to the interview based
CGI-SS-score as “suicidal” (n = 25) than in patients clas-
sified as “non-suicidal” (n = 27) (Table 2).
The sensitivity and specificity of the SUAS-S was ex-
plored as tabulated in Table 3.
A cut-off value of 29 on the SUAS-S scale yielded a
sensitivity of 80% and specificity of 56%. The negative
and positive predictive probabilities of this chosen cut-
off point were 75% and 63%, respectively.Table 5 Intercorrelations with 95% CIs between the five
areas of SUAS-S, BSS-5, BDI and BHS sum scores
BSS-5 BDI BHS
Affect 0.52 (0.27-0.73) 0.75 (0.61-0.84) 0.76 (0.60-0.87)
Bodily States 0.22 (-0.07-0.49) 0.50 (0.27-0.69) 0.29 (0.00-0.54)
CaC 0.40 (0.11-0.64) 0.57 (0.32-0.74) 0.55 (0.31-0.73)
ER 0.36 (0.09-0.60) 0.65 (0.43-0.81) 0.60 (0.37-0.76)
StaB 0.81 (0.69-0.89) 0.68 (0.50-0.80) 0.67 (0.46-0.81)
CaC: Control and coping, ER: Emotional reactivity, STaB: Suicidal thoughts and
behaviour.Identification of suicidality, depression and hopelessness
Descriptive and association analyses of the five areas of
the SUAS-S scale, with a categorical classification as sui-
cidal on the CGI-SS scale as the dependent variable,
showed that the sum scores of the area “suicidal thoughts
and behaviour” (SUAS-S items 16–20) was strongly
associated with this variable (p < 0.001). The other three
areas, “bodily states”, “control and coping” and “emo-
tional reactivity” were not significantly associated withthis dependent variable. The results of analyses are
shown in Table 4.
Pairwise associations between the BSS-5, depression,
hopelessness and the sum scores of the five areas are
shown in Table 5.
Correlation analyses showed that the SUAS-S areas of
“affect” and “suicidal thoughts and behaviour” and “emo-
tional reactivity” were strongly and significantly associated
with depression and hopelessness (r ≥ 0.6, p < 0.001). The
“bodily states” area was significantly correlated with de-
pression (expressed by the BDI sum score) but not with
hopelessness (expressed by the BHS sum score). The as-
sociation was strongest between the sum scores of
the area “suicidal thoughts and behaviour” and BSS-5
(r ≥ 0.8, p < 0.001). The results of correlation analyses are
shown in Table 5.
Figure 2 shows receiver operating characteristic (ROC)
curves of the sensitivity (true positive rate) versus 1–
specificity (the true negative rate) of the test. The dis-
criminatory performance of the test is summarized by
the area under the ROC curve. The larger the area under
the ROC curve, the better the discrimination. For a
given cut-off point, the closer both sensitivity and speci-
ficity (i.e., 1–specificity, close to zero) are to 1, the better
the discriminatory performance. As shown in the figure,
no significant psychometric differences were found in
the ROC analyses for the SUAS-S 0.74 (95% CI: 0.60–0.87)
or BSS-5 0.81 (95% CI: 0.70–0.92), (p =0.238).
Discussion
The psychometric properties of the Norwegian language
version of the SUAS-S in a non-emergency psychiatric
outpatient setting were found to be good, with internal
consistency and test–retest reliability properties compar-
able to the original version. Likewise, the construct val-
idity was found to be favourable. Of the five areas in the
SUAS-S, the “suicidal thoughts and behaviour” subscale
was significantly and strongly associated with the clini-
cian’s global assessment of suicidality. The findings of a
strong correlation between the SUAS-S and BSS-5 (0.66),
and no significant difference between the ROCs for these
two scales (Figure 2), suggests that the SUAS-S is able to
Figure 2 Receiver operating characteristic curves for SUAS-S with BSS-5 to diagnose suicidality.
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ing a cut-off-value of 29, a sensitivity of 80% and a speci-
ficity of 56% were attained (Table 3). In the context of
clinical suicide assessment, these specificity and sensitiv-
ity levels may be regarded as adequate. That the SUAS-S
scores were highly correlated with the BDI-scores in the
overall sample and the subgroups, indicate that SUAS-S
may have the benefit of tapping depression in addition
to suicidality. It is important to note that whereas the
BSS-5 is a short screening instrument, the SUAS-S taps
several additional clinically important dimensions rele-
vant to assessment and management of suicidal patients
in a clinical context. The SUAS-S seems also, as evident
from Figure 1, to be sensitive to lower symptom levels
which may well be of value when monitoring the clinical
course with repeated measurements to evaluate treat-
ment response and detect signs of relapse.
Limitations
The limited number of patients excluded the possibility
to study the SUAS-S properties in more narrow diagnos-
tic subgroups. The selection criteria applied in this study
with exclusion of on-going substance abuse and psych-
otic disorders limits the external validity of findings to
non-psychotic and non-abusing patients in non-emergency
psychiatric evaluation settings.
Conclusions
The Norwegian language version of the SUAS-S was
found to possess psychometric properties equal to theoriginal version and seems to be a valid and reliable in-
strument in the assessment of suicide risk and depres-
sion among patients in the mental health care system.
The SUAS-S also has the advantage of open access with
no copyright costs.Additional file
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